z-logo
open-access-imgOpen Access
New antiretroviral agent use affects prevalence of HIV drug resistance in clinical care populations
Author(s) -
Thibaut Davy-Méndez,
Joseph J. Eron,
Laurence Brunet,
Oksana Zakharova,
Ann M. Dennis,
Sonia Napravnik
Publication year - 2018
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/qad.0000000000001990
Subject(s) - antiretroviral drug , human immunodeficiency virus (hiv) , hiv drug resistance , drug resistance , medicine , drug , antiretroviral agents , sida , lentivirus , antiretroviral therapy , virology , viral disease , viral load , pharmacology , biology , microbiology and biotechnology
To estimate the prevalence of HIV drug resistance over time and identify risk factors for multiclass resistance.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here